Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Windlas Biotech Limited
WINDLAS | NSE
860.05
INR-34.50
-3.86%
WINDLAS | NSE
Loading StockChartView...
About Windlas Biotech Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
860.05
Open
866.80
High
875.95
Low
842.00
Windlas Biotech Limited contract development and manufacturing organization (CDMO) manufactures and trades in pharmaceutical products in India. It offers CDMO services including product discovery product development licensing and commercial manufacturing of generic products. The company also provides manufactures various domestic trade generics and over-the-counter brands which include nutraceutical and health supplement products through the online and offline channels. In addition it manufactures pills capsules pouches sachets and liquid bottles; and generic products portfolio comprises fixed dosage combinations fixed dosage plus modified release combinations customized generics and chewable or dispersible. It exports its products primarily to Cambodia Ivory Coast the Philippines Thailand Vietnam Myanmar and Sri Lanka. The company was incorporated in 2001 and is based in Gurugram India.
View LessWINDLAS | NSE
Risk
38.2
Sharpe
-0.72
Luna's Score
51/100
Recommendation
Hold
Luna says (WINDLAS | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
40.6%1 month
38.2%3 months
36.2%6 months
35.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
35.85
Fwd. PE
-
Price to book
4.72
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
21.00
Ent. to rev.
3.06
PEG
-
Other Fundamentals
EBITDA
795.44M
MarketCap
18.04B
MarketCap(USD)
188.51M
Div. yield
0.54
Op. margin
8.38
Erngs. growth
11.20
Rev. growth
21.00
Ret. on equity
13.66
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
120.95
Range1M
173.80
Range3M
231.10
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.23
Price X volume
58.04M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 21.00 | 24.85 | Par |
| Ent. to Revenue | 3.06 | 11.40 | Cheaper |
| PE Ratio | 35.85 | 51.36 | Cheaper |
| Price to Book | 4.72 | 6.83 | Cheaper |
| Dividend Yield | 0.54 | 0.52 | Par |
| Std. Deviation (3M) | 36.22 | 42.17 | Par |
| Debt to Equity | 0.01 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 18.04B | 290.82B | Emerging |
